The Quantellect read.As of Nov 19, 2026, 15 active firms cover iRhythm Technologies Inc: 14 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $147.00 to $205.00, so the covering firms are broadly aligned. The average target of $172.53 sits 82% above the current $94.88. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 12 to 14 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.10 next quarter toward $1.54 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 active firms
Buy
Strong Buy00%
Buy1493%
Neutral17%
Sell00%
Strong Sell00%
Based on 15 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$172.53
+81.8% upside
Average target across 15 active firms as of Nov 19, 2026 vs $94.88 current
Highest Target$205.00
Average Target$172.53
Lowest Target$147.00
Detailed analyst forecasts for IRTC
Showing 1–15 of 15 named analysts shown · 15 active firms in the rating projection
As of Nov 19, 2026, 14 of 15 active firms rate IRTC a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
IRTC EPS & revenue forecast
EPS · NEXT QUARTER
$-0.10
Range $-0.35 – $0.23 · 11 analysts · -72% YoY
Next period, 11 analysts expect iRhythm Technologies Inc to earn $-0.10 a share (range $-0.35 – $0.23), versus $-0.35 a year earlier. Full-year consensus is $1.29, growing to $1.54 the year after.
REVENUE · NEXT QUARTER
$243.5M
Range $237.6M – $256.7M · 11 analysts · +22% YoY
Revenue is expected to reach $243.5M (range $237.6M – $256.7M), +22.1% year-over-year. Full-year consensus is $893.1M, rising to $1.1B next year.
Top analysts covering iRhythm Technologies Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IRTC.
#1
Joanne Wuensch
Citigroup · Rank #35
Neutral
$124.00+30.7% to target
Overall win rate
51%
+ Follow
#2
MC
Mason Carrico
Stephens & Co. · Rank #178
Buy
$160.00+68.6% to target
Overall win rate
40%
+ Follow
#3
Ryan Zimmerman
BTIG · Rank #212
Buy
$195.00+105.5% to target
Overall win rate
37%
+ Follow
#4
Vijay Kumar
Evercore ISI Group · Rank #331
Buy
$165.00+73.9% to target
Overall win rate
36%
+ Follow
#5
William Plovanic
Canaccord Genuity · Rank #370
Buy
$206.00+117.1% to target
Overall win rate
38%
+ Follow
IRTC stock forecast FAQ
What is IRTC's average 12-month price target?+
The 15 active firms with a live target average $172.53 for iRhythm Technologies Inc over the next 12 months, ranging from a $205.00 high to a $147.00 low, as of Nov 19, 2026.
Is IRTC stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 15 active firms as of Nov 19, 2026, 14 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for IRTC?+
The Street-high target is $205.00 (Morgan Stanley), and the Street-low is $147.00 (Goldman Sachs). The average of all 15 active-firm targets is $172.53.
How many active Wall Street firms cover IRTC?+
15 active firms have a recognized rating on iRhythm Technologies Inc as of Nov 19, 2026, and 15 active firms carry a live 12-month price target.
Who is the most accurate analyst covering IRTC?+
Among analysts who currently cover IRTC, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Neutral with a $124.00 target.
What is iRhythm Technologies Inc's projected EPS for next quarter?+
The consensus estimate is $-0.10 per share (range $-0.35 – $0.23) across 11 analysts. Full-year EPS is projected at $1.29, rising to $1.54 the following year.
How much revenue is iRhythm Technologies Inc expected to report next quarter?+
Consensus revenue is $243.5M (range $237.6M – $256.7M). Full-year revenue is projected at $893.1M, growing to $1.1B next year.
Have analysts been upgrading or downgrading IRTC lately?+
As of Nov 19, 2026, 14 of 15 active firms rate IRTC a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IRTC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.